Brotizolam
Brotizolam is a drug which is thienobenzodiazepine (a benzodiazepine derivative). It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties and is considered to be similar in effect to short-acting benzodiazepines such as triazolam. It is used in the short term treatment of insomnia although due to its short half life it is considered to have relatively high abuse potential and so would not be a first-line treatment.
Primary Characteristics
It is of Synthetic origin.
Molecular Weight: 393.7 · Non-proprietary name: Brotizolam.

Pharmacokinetics
Distribution: Brotizolam has a plasma protein binding is 90%.
Elimination: it is metabolised via Hepatic, plasma half-life is 4.4 hours.
Advertisement
Indications
Brotizolam is primarily indicated in conditions like Insomnia.
Brotizolam is also indicated for secondary conditions like Premedication before surgery.
Contraindications
Brotizolam is contraindicated in conditions like Respiratory disease, Liver diseases, Close-angle glaucoma, Pregnancy, Lactation, Hypersensitivity to the drug.
Dosage
Brotizolam's dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 1 mg | 1 mg | — | oral | |
| Paediatric Dosage (20kg) | ||||
| No data. | ||||
| Neonatal Dosage (3kg) | ||||
| No data. | ||||
Drug Interactions
None recorded.
Side Effects
Brotizolam in overdosage may give rise to further complications which include Urticaria , Dermatitis , Hypertension , Psychosis , Tachycardia , Jaundice .
Brotizolam is known to cause more or less tolerable side effects which are usually transient. These include Ataxia, Confusion, Depression, GI upset, Headache, Hypersalivation , Slurred speech, Somnolence .
Warnings / Precautions
Available Brands
None recorded.
Storage Conditions
Drug Classification
- 1.5 — Anticonvulsants and Antiepileptics
- 2.24.3 — Drugs used in anxiety and sleep disorders